Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market report explains the definition, types, applications, major countries, and major players of the Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GlaxoSmithKline
Pfizer Inc
Lanzhou Institute of Biological Products CO LTD
AstraZeneca
Novartis AG
Emergent BioSolutions Inc
Sanofi Pasteur
Protein Sciences Corporation
Johnson & Johnson
Seqirus
Astellas Pharma US Inc
Merck Sharp & Dohme Corp
By Type:
Immune DTaP Vaccine
Therapy DTaP Vaccine
By End-User:
Adult
Pediatric
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Outlook to 2028- Original Forecasts
-
2.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market- Recent Developments
-
6.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market News and Developments
-
6.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Deals Landscape
7 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials and Cost Structure Analysis
-
7.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Raw Materials
-
7.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Trend of Key Raw Materials
-
7.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Suppliers of Raw Materials
-
7.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Concentration Rate of Raw Materials
-
7.5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Cost Structure Analysis
-
7.5.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Materials Analysis
-
7.5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Labor Cost Analysis
-
7.5.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Expenses Analysis
8 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export Analysis (Top 10 Countries)
-
8.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Export by Region (Top 10 Countries) (2017-2028)
9 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immune DTaP Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Therapy DTaP Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pediatric Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Outlook till 2022
-
10.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.2.2 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.2.3 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.2 UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.3 Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.4 Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.5 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.6 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.7 Denmark Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.8 Finland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.9 Norway Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.10 Sweden Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.11 Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.12 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.3.13 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.4 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.5 Pakistan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.6 Bangladesh Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.7 Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.8 Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.9 Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.10 Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.11 Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.4.12 Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.2 Colombia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.3 Chile Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.4 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.5 Venezuela Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.6 Peru Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.7 Puerto Rico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.5.8 Ecuador Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6.2 Kuwait Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6.3 Oman Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6.4 Qatar Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6.5 Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.6.6 United Arab Emirates Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.7.2 South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.7.3 Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.7.4 Algeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
-
10.8.2 New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (2017-2022)
11 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Competitive Analysis
-
11.1 GlaxoSmithKline
-
11.1.1 GlaxoSmithKline Company Details
-
11.1.2 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.1.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer Inc
-
11.2.1 Pfizer Inc Company Details
-
11.2.2 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.2.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Lanzhou Institute of Biological Products CO LTD
-
11.3.1 Lanzhou Institute of Biological Products CO LTD Company Details
-
11.3.2 Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.3.4 Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 AstraZeneca
-
11.4.1 AstraZeneca Company Details
-
11.4.2 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.4.4 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis AG
-
11.5.1 Novartis AG Company Details
-
11.5.2 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.5.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Emergent BioSolutions Inc
-
11.6.1 Emergent BioSolutions Inc Company Details
-
11.6.2 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.6.4 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sanofi Pasteur
-
11.7.1 Sanofi Pasteur Company Details
-
11.7.2 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.7.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Protein Sciences Corporation
-
11.8.1 Protein Sciences Corporation Company Details
-
11.8.2 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.8.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Johnson & Johnson
-
11.9.1 Johnson & Johnson Company Details
-
11.9.2 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Seqirus
-
11.10.1 Seqirus Company Details
-
11.10.2 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.10.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Astellas Pharma US Inc
-
11.11.1 Astellas Pharma US Inc Company Details
-
11.11.2 Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.11.4 Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Merck Sharp & Dohme Corp
-
11.12.1 Merck Sharp & Dohme Corp Company Details
-
11.12.2 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
11.12.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Outlook by Types and Applications to 2028
-
12.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Immune DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Therapy DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis and Outlook to 2028
-
13.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.2.2 Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.2.3 Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.2 UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.3 Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.4 Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.5 France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.6 Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.7 Denmark Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.8 Finland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.9 Norway Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.10 Sweden Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.11 Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.12 Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.3.13 Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.3 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.4 South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.8 Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.9 Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.11 Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.2 Colombia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.3 Chile Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.4 Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.6 Peru Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6.3 Oman Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6.4 Qatar Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.7.2 South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.7.3 Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.7.4 Algeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
-
Figure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Picture
-
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Immune DTaP Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Therapy DTaP Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Consumption and Growth Rate (2017-2022)
-
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Denmark Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Finland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Norway Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Sweden Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Colombia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Chile Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Peru Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table GCC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure Bahrain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Oman Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Qatar Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Algeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table Oceania Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Country (2017-2022)
-
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption and Growth Rate (2017-2022)
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Lanzhou Institute of Biological Products CO LTD Company Details
-
Table Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Lanzhou Institute of Biological Products CO LTD Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Emergent BioSolutions Inc Company Details
-
Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Sanofi Pasteur Company Details
-
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Protein Sciences Corporation Company Details
-
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Seqirus Company Details
-
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Astellas Pharma US Inc Company Details
-
Table Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Astellas Pharma US Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Table Merck Sharp & Dohme Corp Company Details
-
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
-
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Portfolio
-
Figure Global Immune DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Therapy DTaP Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Germany Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Brazil Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast by Country (2022-2028)
-
Figure Australia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
